This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Albert-Ludwigs-Universitaet Freiburg, Albert-Ludwigs-Universitat Freiburg, Cellectis. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 47 
1 out of 95 
1 out of 101 
Years Active: 2021-2025
Title: Claudio Mussolino: Innovator in Cell Therapy and Gene Modification
Introduction
Claudio Mussolino is a prominent inventor based in Freiburg, Germany. He has made significant contributions to the fields of cell therapy and HIV treatments. With a total of two patents to his name, Mussolino's work focuses on developing innovative solutions for medical challenges.
Latest Patents
Mussolino's latest patents include "Sequence specific reagents targeting CCR5 in primary hematopoietic cells." This invention pertains to the field of cell therapy and HIV treatments. It provides highly specific reagents for reducing or inactivating the expression of CCR5 in primate and human primary cells, especially in the form of TALE-nucleases. These reagents enable the production of safer primary hematopoietic cells that are resistant to HIV, stem cells, or differentiated cells for infusion into HIV patients. Another notable patent is the "Construct for epigenetic modification and its use in the silencing of genes." This construct is designed for epigenomic modification of genes and includes components that can silence genes coding for proteins in leukocytes, thereby preventing the internalization of HIV viruses in immune cells.
Career Highlights
Mussolino has worked at notable institutions, including Albert-Ludwigs-Universität Freiburg and Cellectis. His research has significantly advanced the understanding and treatment of HIV, showcasing his commitment to improving patient outcomes through innovative therapies.
Collaborations
Mussolino has collaborated with esteemed colleagues such as Toni Cathomen and Tatjana Cornu. These partnerships have further enriched his research and contributed to the development of groundbreaking technologies in the field.
Conclusion
Claudio Mussolino stands out as an influential inventor in the realm of cell therapy and gene modification. His patents reflect a dedication to addressing critical health issues, particularly in the fight against HIV. His work continues to inspire advancements in medical science and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile